Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2524)
  3. Review (119)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5692)
  2. Department of Medicine (5682)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (664)
  5. Michael Morris (587)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (200)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (302)

More Publishers

Results (5692)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The association between drug industry payments and NCCN guideline panel membership
    Meeting Abstract

    Mitchell, A. P.; Mishra, A. A.; Dey, P.; Curry, M. A.; Trivedi, N. A.; Haddadin, M.; Rahman, M.; Winn, A. N.; Dusetzina, S.; Bach, P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Results of a phase II trial of intense androgen deprivation therapy prior to radical prostatectomy (RP) in men with high-risk localized prostate cancer (PC)
    Meeting Abstract

    McKay, R. R.; Xie, W.; Fennessy, F. M.; Zhang, Z.; Lis, R.; Rathkopf, D. E.; Laudone, V. P.; Bubley, G.; Einstein, D. J.; Chang, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors: The PEACE randomized controlled trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Panageas, K.; Baser, R. E.; Romero, S. A. D.; Li, Q. S.; Xiao, H.; Bao, T.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings
    Meeting Abstract

    Lyou, Y.; Grivas, P.; Rosenberg, J. E.; Hoffman-Censits, J. H.; Quinn, D. I.; Petrylak, D. P.; Galsky, M. D.; Vaishampayan, U. N.; De Giorgi, U.; Gupta, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for disease progression after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell renal cell carcinoma (mccRCC)
    Meeting Abstract

    Lee, C. H.; Shah, A. Y.; Hsieh, J. J.; Rao, A.; Pinto, A.; Bilen, M. A.; Cohn, A. L.; Di Simone, C.; Shaffer, D. R.; Sarrio, R. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicity (Q-TWiST) of lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Lee, C. H.; Wan, Y.; Smith, A. D.; Xie, R.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Brannon, A. R.; Zehir, A.; Arcila, M. E.; Benayed, R.; Chaft, J. E.; Drilon, A. E.; Kris, M. G.; Gomez, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers
    Meeting Abstract

    Latham, A.; Salo-Mullen, E. E.; Catchings, A.; Ranganathan, M.; Fiala, E.; Kemel, Y.; Konner, J. A.; Soslow, R. A.; Momeni-Boroujeni, A.; Shia, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations
    Meeting Abstract

    Janku, F.; Elez, E.; Iyer, G.; Yamamoto, N.; Tan, D. S. W.; Stathis, A.; Stammberger, U. M.; Evans, H.; Seroutou, A.; Mais, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save